Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in saudi arabia and kuwait: results from the zerbini study

HIGHLIGHTS

• who: Khalid Al Faraidy et al. from the subjects with hyperlipidemia in Saudi Arabia Cardiac Centre, Riyadh, Saudi Arabia, King Abdulaziz University, Clinical Biochemistry Jeddah University have published the research: Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study, in the Journal: PLOS ONE of 17/09/2022
• what: This study aimed to describe the characteristics of patients receiving evolocumab in clinical practice. Patients were excluded from persistence calculations if they did not complete the study for reasons that were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.